V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014348 | 270014704 | null | 69.4 | Adjuvant (A) | 2013-10-18 | 2013-10-30 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | 02 | N | 270017624 | NIVOLUMAB |
| 270014349 | 270010079 | 1.7 | 105.4 | Palliative (P) | 2013-11-20 | 2013-11-26 | GDP | 01 | null | 270017635 | GDP |
| 270014350 | 270014706 | 1.85 | 95 | Curative (C) | 2015-07-22 | 2015-07-22 | Cisplatin 7 day | N | N | 270017635 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270014351 | 270014706 | 1.85 | 68.8 | null | 2014-09-25 | 2014-09-28 | IVE | N | N | 270017635 | IVE |
| 270014352 | 270019264 | 1.8 | 89.4 | Palliative (P) | 2013-12-19 | 2014-01-02 | Cyclophosphamide High Dose | N | N | 270017661 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014353 | 270010083 | null | 53 | Curative (C) | 2013-08-31 | 2013-10-12 | NIVOLUMAB | N | N | 270017673 | PANITUMUMAB |
| 270014354 | 270014708 | 1.7 | 98 | Adjuvant (A) | null | 2013-11-29 | VEPEMB | null | null | 270017681 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014355 | 270010087 | 1.76 | 71.24 | Adjuvant (A) | null | 2017-01-28 | Gemcitabine weekly | 02 | null | 270017686 | PANITUMUMAB |
| 270014356 | 270010089 | 1.77 | 76.6 | Adjuvant (A) | 2014-04-04 | 2014-04-13 | BEAM + Alemtuzumab Allo SCT | 2 | N | 270017728 | BEAM + ALEMTUZUMAB |
| 270014357 | 270010089 | 1.68 | 129.5 | Palliative (P) | 2018-07-27 | 2018-08-13 | R ABVD | null | null | 270017728 | OXALIPLATIN + RALTITREXED |
| 270014358 | 270010092 | 1.89 | 87.8 | null | 2015-11-20 | 2016-03-25 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 270017775 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014359 | 270010092 | 1.67 | 62.8 | Adjuvant (A) | 2013-03-16 | 2013-04-02 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270017775 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014360 | 270017118 | 1.57 | 69 | Adjuvant (A) | 2018-08-02 | 2018-08-30 | Irinotecan 14day | N | N | 270017787 | IRINOTECAN |
| 270014362 | 270010097 | 1.8 | null | Palliative (P) | 2017-09-10 | 2017-10-03 | Cisplatin 7 day | 2 | N | 270017792 | BEVACIZUMAB |
| 270014363 | 270014716 | 1.64 | 75.3 | Palliative (P) | 2015-04-17 | 2015-04-17 | Oxaliplatin + Raltitrexed | 02 | N | 270017800 | IGEV |
| 270014364 | 270017120 | 1.64 | 47 | null | 2016-11-16 | 2017-03-26 | Cyclophosphamide High Dose | 02 | N | 270017800 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014365 | 270010101 | 1.73 | 118 | null | 2013-05-24 | 2013-06-14 | Cyclophosphamide High Dose | N | N | 270017822 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014366 | 270010104 | 1.66 | 81.6 | Palliative (P) | 2015-09-12 | 2015-09-12 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | 2 | null | 270017826 | BEAM + ALEMTUZUMAB |
| 270014367 | 270014719 | 1.54 | 74.6 | Adjuvant (A) | 2016-12-19 | 2017-02-06 | Carboplatin AUC 6 - 10 | null | null | 270017834 | VEPEMB |
| 270014368 | 270017122 | 1.58 | 68.4 | Curative (C) | 2014-02-07 | 2014-02-07 | GDP | 02 | N | 270017849 | GDP |
| 270014369 | 270017122 | 1.55 | 59 | Adjuvant (A) | 2013-12-06 | 2013-12-13 | CISPLATIN + GEMCITABINE | N | N | 270017849 | PANITUMUMAB |
| 270014370 | 270017122 | 1.61 | null | Curative (C) | 2017-10-19 | 2018-01-20 | NIVOLUMAB | 02 | N | 270017849 | CARBOPLATIN |
| 270014371 | 270010106 | 1.78 | null | Palliative (P) | 2017-05-04 | 2017-05-05 | Cisplatin | 02 | N | 270017881 | CISPLATIN |
| 270014372 | 270010108 | 1.74 | 115 | Curative (C) | 2015-05-03 | 2015-05-16 | NIVOLUMAB | N | N | 270017888 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014373 | 270010110 | 1.7 | 86 | Palliative (P) | 2016-12-02 | 2016-12-09 | GEM-P | 2 | N | 270017893 | GEMCITABINE + PACLITAXEL |
| 270014374 | 270010111 | 1.78 | 140 | Palliative (P) | 2017-10-19 | 2017-10-22 | GEMCITABINE | N | N | 270017902 | CISPLATIN + GEMCITABINE |
| 270014375 | 270010112 | 1.58 | 88 | Palliative (P) | 2017-07-14 | 2017-07-15 | Cyclophosphamide High Dose | 02 | N | 270017902 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014376 | 270018486 | 1.71 | null | Adjuvant (A) | 2014-10-28 | 2014-11-06 | Oxaliplatin + Raltitrexed | 02 | N | 270017933 | BEVACIZUMAB |
| 270014377 | 270014724 | 1.8 | 81.4 | Adjuvant (A) | 2014-05-12 | 2014-05-19 | Oxaliplatin + Raltitrexed | N | N | 270017938 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014378 | 270010116 | 1.82 | null | Palliative (P) | 2015-04-22 | 2015-08-02 | Cyclophosphamide High Dose | N | N | 270017940 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014379 | 270010117 | 1.8 | 63 | Palliative (P) | 2016-03-30 | 2016-04-20 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 270017987 | AFLIBERCEPT + FU + IRINOTECAN |
| 270014380 | 270010117 | 1.83 | 87.6 | Adjuvant (A) | 2016-07-26 | 2016-08-11 | Cyclophosphamide High Dose | 2 | N | 270017987 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014381 | 270010117 | 1.7 | 108 | Palliative (P) | 2016-12-05 | 2016-12-05 | Cyclophosphamide High Dose | N | N | 270017987 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014382 | 270010117 | 1.88 | null | Not known (9) | 2015-02-20 | 2015-02-21 | Irinotecan 14day | N | N | 270017987 | IRINOTECAN |
| 270014383 | 270010118 | 1.88 | 65.9 | Curative (C) | 2016-03-31 | 2016-04-08 | Irinotecan | 2 | N | 270018051 | IRINOTECAN |
| 270014384 | 270010118 | 1.7 | 75.3 | Curative (C) | 2014-06-13 | 2014-06-16 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | 2 | N | 270018051 | BEAM + ALEMTUZUMAB |
| 270014385 | 270019270 | 1.7 | 87.9 | Disease modification (D) | 2017-09-03 | 2017-09-03 | IVE | 02 | null | 270018100 | IVE |
| 270014386 | 270010120 | 0 | 98 | Palliative (P) | 2016-09-12 | 2016-09-24 | VEPEMB | null | null | 270018100 | VINBLASTINE |
| 270014387 | 270018489 | 1.78 | null | Curative (C) | 2015-10-25 | 2016-07-28 | Irinotecan 14day | 02 | N | 270018110 | IRINOTECAN |
| 270014388 | 270019948 | 1.55 | 33.4 | Curative (C) | 2016-01-22 | 2016-03-17 | Cetuximab + Oxaliplatin + MdG Maint | N | null | 270018129 | ABVD R |
| 270014389 | 270020085 | null | 62.6 | Curative (C) | 2017-07-20 | 2017-07-21 | Panitumumab | N | N | 270018134 | GEMCITABINE |
| 270014390 | 270020162 | 1.57 | 64.7 | Curative (C) | 2015-03-09 | 2015-08-09 | ABVD R | 01 | Y | 270018142 | CARBOPLATIN |
| 270014391 | 270010123 | 1.76 | 59 | Adjuvant (A) | 2014-06-23 | 2014-07-01 | VEPEMB | N | N | 270018161 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270014392 | 270014732 | 1.7 | null | Curative (C) | 2014-03-05 | 2014-03-11 | Cisplatin 7 day | N | N | 270018171 | IGEV |
| 270014393 | 270010129 | 1.71 | 64 | Curative (C) | 2016-11-27 | 2016-12-04 | NIVOLUMAB | 02 | null | 270018177 | CETUXIMAB + OXALIPLATIN + MDG |
| 270014394 | 270010130 | 1.76 | 56 | Disease modification (D) | 2017-04-17 | 2017-04-18 | IVE | N | null | 270018177 | IVE |
| 270014395 | 270010132 | 1.59 | 80.9 | Curative (C) | 2015-07-19 | 2015-07-27 | Cisplatin | N | N | 270018227 | VEPEMB |
| 270014396 | 270010133 | 1.63 | null | Adjuvant (A) | 2015-03-17 | 2015-03-22 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270018236 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270014397 | 270010136 | 1.76 | 78.4 | Adjuvant (A) | 2017-04-09 | 2017-04-09 | Vinblastine | N | N | 270018255 | PANITUMUMAB |
| 270014398 | 270010142 | 1.66 | null | Adjuvant (A) | null | 2016-01-31 | Oxaliplatin + Raltitrexed | 02 | N | 270018269 | VEPEMB |